These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9569171)

  • 1. The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk.
    Després JP
    Obes Res; 1998 Apr; 6 Suppl 1():8S-17S. PubMed ID: 9569171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma high-density lipoprotein cholesterol but not apolipoprotein A-I is a good correlate of the visceral obesity-insulin resistance dyslipidemic syndrome.
    Couillard C; Lamarche B; Tchernof A; Prud'homme D; Tremblay A; Bouchard C; Moorjani S; Nadeau A; Lupien PJ; Després JP
    Metabolism; 1996 Jul; 45(7):882-8. PubMed ID: 8692026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications.
    Després JP; Lemieux S; Lamarche B; Prud'homme D; Moorjani S; Brun LD; Gagné C; Lupien PJ
    Int J Obes Relat Metab Disord; 1995 May; 19 Suppl 1():S76-86. PubMed ID: 7550542
    [No Abstract]   [Full Text] [Related]  

  • 4. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.
    Lamarche B; Lemieux I; Després JP
    Diabetes Metab; 1999 Sep; 25(3):199-211. PubMed ID: 10499189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular disease under the influence of excess visceral fat.
    Després JP
    Crit Pathw Cardiol; 2007 Jun; 6(2):51-9. PubMed ID: 17667865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood obesity, adipose tissue distribution, and the pediatric practitioner.
    Slyper AH
    Pediatrics; 1998 Jul; 102(1):e4. PubMed ID: 9651456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic dyslipidemia.
    Kreisberg RA
    Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity.
    Pascot A; Lemieux I; Prud'homme D; Tremblay A; Nadeau A; Couillard C; Bergeron J; Lamarche B; Després JP
    J Lipid Res; 2001 Dec; 42(12):2007-14. PubMed ID: 11734573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology?
    Lemieux I; Poirier P; Bergeron J; Alméras N; Lamarche B; Cantin B; Dagenais GR; Després JP
    Can J Cardiol; 2007 Oct; 23 Suppl B(Suppl B):23B-31B. PubMed ID: 17932584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health consequences of visceral obesity.
    Després JP
    Ann Med; 2001 Nov; 33(8):534-41. PubMed ID: 11730160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyslipidaemia and obesity.
    Després JP
    Baillieres Clin Endocrinol Metab; 1994 Jul; 8(3):629-60. PubMed ID: 7980350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men.
    Tchernof A; Lamarche B; Prud'Homme D; Nadeau A; Moorjani S; Labrie F; Lupien PJ; Després JP
    Diabetes Care; 1996 Jun; 19(6):629-37. PubMed ID: 8725863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipidemia in visceral obesity: mechanisms, implications, and therapy.
    Chan DC; Barrett HP; Watts GF
    Am J Cardiovasc Drugs; 2004; 4(4):227-46. PubMed ID: 15285698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral fat accumulation contributes to insulin resistance, small-sized low-density lipoprotein, and progression of coronary artery disease in middle-aged non-obese Japanese men.
    Kobayashi H; Nakamura T; Miyaoka K; Nishida M; Funahashi T; Yamashita S; Matsuzawa Y
    Jpn Circ J; 2001 Mar; 65(3):193-9. PubMed ID: 11266194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors associated with obesity: a metabolic perspective].
    Després JP; Pascot A; Lemieux I
    Ann Endocrinol (Paris); 2000 Dec; 61 Suppl 6():31-38. PubMed ID: 11148334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of obesity in primary hyperlipidemias.
    Carmena R; Ascaso JF; Real JT
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):354-9. PubMed ID: 11887432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance and lipid metabolism.
    Howard BV
    Am J Cardiol; 1999 Jul; 84(1A):28J-32J. PubMed ID: 10418856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The apoB-100 gene EcoRI polymorphism influences the relationship between features of the insulin resistance syndrome and the hyper-apoB and dense LDL phenotype in men.
    Vohl MC; Tchernof A; Dionne FT; Moorjani S; Prud'homme D; Bouchard C; Nadeau A; Lupien PJ; Després JP
    Diabetes; 1996 Oct; 45(10):1405-11. PubMed ID: 8826978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral obesity, insulin resistance, and dyslipidemia: contribution of endurance exercise training to the treatment of the plurimetabolic syndrome.
    Després JP
    Exerc Sport Sci Rev; 1997; 25():271-300. PubMed ID: 9213095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.